On Vertex's Q4 earnings call, investors will focus on management's comments about launch preparation for Alyftrek (vanza ...

West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In ...

American Electric Power Company, Inc AEP is slated to release fourth-quarter 2024 results on Feb. 13, before the market opens ...

However, there is a stock that has performed even better than Tesla since Trump’s election victory. Since November, data ...

Disney will report its fiscal first-quarter earnings before the bell on Wednesday, and Wall Street will be paying close attention to the state of its streaming and theme parks businesses. Investors ...

Stock analysts at National Bank Financial increased their FY2024 earnings per share (EPS) estimates for shares of Winpak in a report issued on Sunday, February 2nd. National Bank Financial analyst A.

Major indices on the Wall Street were little changed on Friday as investors tried to make sense of the latest job figures and ...

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

From fast food to fine dining, restaurants play a vital societal role. It also feels like demand is strong as consumers ...

A historically pricey stock market has been a harbinger of trouble to come for Wall Street for more than 150 years, which is why earnings quality from America's most influential businesses is more ...

Learn more about whether Protagonist Therapeutics, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.